Accessible Search Form           Advanced Search

Martha Vaughan, M.D.

Publications


Principal Investigator thumbnail image

Martha Vaughan
Scientist Emeritus

P: +1 301 496 4554
vaughanm@nhlbi.nih.gov


Full Publications Listing

BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein modulates ATP-binding cassette transporter A-1 trafficking and function.
Lin S, Zhou C, Neufeld E, Wang YH, Xu SW, Lu L, Wang Y, Liu ZP, Li D, Li C, Chen S, Le K, Huang H, Liu P, Moss J, Vaughan M, Shen X.
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):e31-8.
[Text Abstract on PubMed]

Brefeldin A-inhibited ADP-ribosylation factor activator BIG2 regulates cell migration via integrin ß1 cycling and actin remodeling.
Shen X, Li CC, Aponte AM, Shen RF, Billings EM, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2012 Sep 4;109(36):14464-9.
[Text Abstract on PubMed]

Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing.
Li CC, Kuo JC, Waterman CM, Kiyama R, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2011 Nov 29;108(48):19228-33.
[Text Abstract on PubMed]

Regulation of growth factor receptor degradation by ADP-ribosylation factor domain protein (ARD) 1.
Meza-Carmen V, Pacheco-Rodriguez G, Kang GS, Kato J, Donati C, Zhang CY, Vichi A, Payne DM, El-Chemaly S, Stylianou M, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2011 Jun 28;108(26):10454-9.
[Text Abstract on PubMed]

Interaction of phosphodiesterase 3A with brefeldin A-inhibited guanine nucleotide-exchange proteins BIG1 and BIG2 and effect on ARF1 activity.
Puxeddu E, Uhart M, Li CC, Ahmad F, Pacheco-Rodriguez G, Manganiello VC, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2009 Apr 14;106(15):6158-63.
[Text Abstract on PubMed]

Interaction of brefeldin A-inhibited guanine nucleotide-exchange protein (BIG) 1 and kinesin motor protein KIF21A.
Shen X, Meza-Carmen V, Puxeddu E, Wang G, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2008 Dec 2;105(48):18788-93.
[Text Abstract on PubMed]

cAMP-dependent protein kinase A (PKA) signaling induces TNFR1 exosome-like vesicle release via anchoring of PKA regulatory subunit RIIbeta to BIG2.
Islam A, Jones H, Hiroi T, Lam J, Zhang J, Moss J, Vaughan M, Levine SJ.
J. Biol. Chem. 2008 Sep 12;283(37):25364-71.
[Text Abstract on PubMed]

Association of guanine nucleotide-exchange protein BIG1 in HepG2 cell nuclei with nucleolin, U3 snoRNA, and fibrillarin.
Padilla PI, Uhart M, Pacheco-Rodriguez G, Peculis BA, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2008 Mar 4;105(9):3357-61.
[Text Abstract on PubMed]

Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1.
Citterio C, Vichi A, Pacheco-Rodriguez G, Aponte AM, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2008 Feb 26;105(8):2877-82.
[Text Abstract on PubMed]

The brefeldin A-inhibited guanine nucleotide-exchange protein, BIG2, regulates the constitutive release of TNFR1 exosome-like vesicles.
Islam A, Shen X, Hiroi T, Moss J, Vaughan M, Levine SJ.
J. Biol. Chem. 2007 Mar 30;282(13):9591-9.
[Text Abstract on PubMed]

Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.
Kuroda F, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2007 Feb 27;104(9):3201-6.
[Text Abstract on PubMed]

BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1.
Shen X, Hong MS, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2007 Jan 23;104(4):1230-5.
[Text Abstract on PubMed]

GEP100/BRAG2: activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and alpha-catenin.
Hiroi T, Someya A, Thompson W, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2006 Jul 11;103(28):10672-7.
[Text Abstract on PubMed]

Effect of protein kinase A on accumulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) in HepG2 cell nuclei.
Citterio C, Jones HD, Pacheco-Rodriguez G, Islam A, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2006 Feb 21;103(8):2683-8.
[Text Abstract on PubMed]

Association of brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) with recycling endosomes during transferrin uptake.
Shen X, Xu KF, Fan Q, Pacheco-Rodriguez G, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2006 Feb 21;103(8):2635-40.
[Text Abstract on PubMed]

Interaction of BIG2, a brefeldin A-inhibited guanine nucleotide-exchange protein, with exocyst protein Exo70.
Xu KF, Shen X, Li H, Pacheco-Rodriguez G, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2005 Feb 22;102(8):2784-9.
[Text Abstract on PubMed]

E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1).
Vichi A, Payne DM, Pacheco-Rodriguez G, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2005 Feb 8;102(6):1945-50.
[Text Abstract on PubMed]

BIG1 and BIG2, brefeldin A-inhibited guanine nucleotide-exchange factors for ADP-ribosylation factors.
Jones HD, Moss J, Vaughan M.
Meth. Enzymol. 2005;404:174-84.
[Text Abstract on PubMed]

Cytohesin-1: structure, function, and ARF activation.
Pacheco-Rodriguez G, Moss J, Vaughan M.
Meth. Enzymol. 2005;404:184-95.
[Text Abstract on PubMed]

ADP-ribosylation factor domain protein 1 (ARD1), a multifunctional protein with ubiquitin E3 ligase, GAP, and ARF domains.
Vichi A, Moss J, Vaughan M.
Meth. Enzymol. 2005;404:195-206.
[Text Abstract on PubMed]

Nuclear localization and molecular partners of BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
Padilla PI, Pacheco-Rodriguez G, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2004 Mar 2;101(9):2752-7.
[Text Abstract on PubMed]

Nonobstructive renal causes of flank pain: findings on noncontrast helical CT (CT KUB).
Talner L, Vaughan M.
Abdom Imaging. 2003 Mar-Apr;28(2):210-6.
[Text Abstract on PubMed]

Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).
Li H, Adamik R, Pacheco-Rodriguez G, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2003 Feb 18;100(4):1627-32.
[Text Abstract on PubMed]

Activation of phospholipase D by bradykinin and sphingosine 1-phosphate in A549 human lung adenocarcinoma cells via different GTP-binding proteins and protein kinase C delta signaling pathways.
Meacci E, Nuti F, Catarzi S, Vasta V, Donati C, Bourgoin S, Bruni P, Moss J, Vaughan M.
Biochemistry. 2003 Jan 21;42(2):284-92.
[Text Abstract on PubMed]

Cytohesin-1 in 2001.
Moss J, Vaughan M.
Arch. Biochem. Biophys. 2002 Jan 15;397(2):156-61.
[Text Abstract on PubMed]

ARF-directed guanine-nucleotide-exchange (GEP) proteins.
Pacheco-Rodriguez G, Moss J, Vaughan M.
Methods Mol. Biol. 2002;189:181-9.
[Text Abstract on PubMed]

ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6.
Someya A, Sata M, Takeda K, Pacheco-Rodriguez G, Ferrans VJ, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2001 Feb 27;98(5):2413-8.
[Text Abstract on PubMed]

Isolation, cloning, and characterization of brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factor.
Pacheco-Rodriguez G, Moss J, Vaughan M.
Meth. Enzymol. 2001;329:300-6.
[Text Abstract on PubMed]

Purification and properties of ARD1, an ADP-ribosylation factor (ARF)-related protein with GTPase-activating domain.
Vitale N, Moss J, Vaughan M.
Meth. Enzymol. 2001;329:324-34.
[Text Abstract on PubMed]

Preparation and assay of recombinant ADP-ribosylation factor-like protein-1 (ARL1).
Pacheco-Rodriguez G, Moss J, Vaughan M.
Meth. Enzymol. 2001;329:424-8.
[Text Abstract on PubMed]

Identification of lysosomal and Golgi localization signals in GAP and ARF domains of ARF domain protein 1.
Vitale N, Ferrans VJ, Moss J, Vaughan M.
Mol. Cell. Biol. 2000 Oct;20(19):7342-52.
[Text Abstract on PubMed]

Specific functional interaction of human cytohesin-1 and ADP-ribosylation factor domain protein (ARD1).
Vitale N, Pacheco-Rodriguez G, Ferrans VJ, Riemenschneider W, Moss J, Vaughan M.
J. Biol. Chem. 2000 Jul 14;275(28):21331-9.
[Text Abstract on PubMed]

GIT proteins, A novel family of phosphatidylinositol 3,4, 5-trisphosphate-stimulated GTPase-activating proteins for ARF6.
Vitale N, Patton WA, Moss J, Vaughan M, Lefkowitz RJ, Premont RT.
J. Biol. Chem. 2000 May 5;275(18):13901-6.
[Text Abstract on PubMed]

Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.
Yamaji R, Adamik R, Takeda K, Togawa A, Pacheco-Rodriguez G, Ferrans VJ, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 2000 Mar 14;97(6):2567-72.
[Text Abstract on PubMed]

Similarities in function and gene structure of cytohesin-4 and cytohesin-1, guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Ogasawara M, Kim SC, Adamik R, Togawa A, Ferrans VJ, Takeda K, Kirby M, Moss J, Vaughan M.
J. Biol. Chem. 2000 Feb 4;275(5):3221-30.
[Text Abstract on PubMed]

Effect of Rho and ADP-ribosylation factor GTPases on phospholipase D activity in intact human adenocarcinoma A549 cells.
Meacci E, Vasta V, Moorman JP, Bobak DA, Bruni P, Moss J, Vaughan M.
J. Biol. Chem. 1999 Jun 25;274(26):18605-12.
[Text Abstract on PubMed]

Brefeldin A inhibited activity of the sec7 domain of p200, a mammalian guanine nucleotide-exchange protein for ADP-ribosylation factors.
Morinaga N, Adamik R, Moss J, Vaughan M.
J. Biol. Chem. 1999 Jun 18;274(25):17417-23.
[Text Abstract on PubMed]

Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
Togawa A, Morinaga N, Ogasawara M, Moss J, Vaughan M.
J. Biol. Chem. 1999 Apr 30;274(18):12308-15.
[Text Abstract on PubMed]

Structural elements of ADP-ribosylation factor 1 required for functional interaction with cytohesin-1.
Pacheco-Rodriguez G, Patton WA, Adamik R, Yoo HS, Lee FJ, Zhang GF, Moss J, Vaughan M.
J. Biol. Chem. 1999 Apr 30;274(18):12438-44.
[Text Abstract on PubMed]

Structural basis for the inhibitory effect of brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Sata M, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1999 Mar 16;96(6):2752-7.
[Text Abstract on PubMed]

Activation of toxin ADP-ribosyltransferases by eukaryotic ADP-ribosylation factors.
Moss J, Vaughan M.
Mol. Cell. Biochem. 1999 Mar;193(1-2):153-7.
[Text Abstract on PubMed]

Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors.
Stevens LA, Moss J, Vaughan M, Pizza M, Rappuoli R.
Infect. Immun. 1999 Jan;67(1):259-65.
[Text Abstract on PubMed]

beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein.
Premont RT, Claing A, Vitale N, Freeman JL, Pitcher JA, Patton WA, Moss J, Vaughan M, Lefkowitz RJ.
Proc. Natl. Acad. Sci. U.S.A. 1998 Nov 24;95(24):14082-7.
[Text Abstract on PubMed]

Guanine nucleotide exchange on ADP-ribosylation factors catalyzed by cytohesin-1 and its Sec7 domain.
Pacheco-Rodriguez G, Meacci E, Vitale N, Moss J, Vaughan M.
J. Biol. Chem. 1998 Oct 9;273(41):26543-8.
[Text Abstract on PubMed]

Molecules in the ARF orbit.
Moss J, Vaughan M.
J. Biol. Chem. 1998 Aug 21;273(34):21431-4.
[Text Abstract on PubMed]

Effects of arfaptin 1 on guanine nucleotide-dependent activation of phospholipase D and cholera toxin by ADP-ribosylation factor.
Tsai SC, Adamik R, Hong JX, Moss J, Vaughan M, Kanoh H, Exton JH.
J. Biol. Chem. 1998 Aug 14;273(33):20697-701.
[Text Abstract on PubMed]

Localization of ADP-ribosylation factor domain protein 1 (ARD1) in lysosomes and Golgi apparatus.
Vitale N, Horiba K, Ferrans VJ, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1998 Jul 21;95(15):8613-8.
[Text Abstract on PubMed]

Phospholipid- and GTP-dependent activation of cholera toxin and phospholipase D by human ADP-ribosylation factor-like protein 1 (HARL1).
Hong JX, Lee FJ, Patton WA, Lin CY, Moss J, Vaughan M.
J. Biol. Chem. 1998 Jun 19;273(25):15872-6.
[Text Abstract on PubMed]

Brefeldin A-inhibited guanine nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian ADP ribosylation factors.
Sata M, Donaldson JG, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1998 Apr 14;95(8):4204-8.
[Text Abstract on PubMed]

Molecular characterization of the GTPase-activating domain of ADP-ribosylation factor domain protein 1 (ARD1).
Vitale N, Moss J, Vaughan M.
J. Biol. Chem. 1998 Jan 30;273(5):2553-60.
[Text Abstract on PubMed]

Signaling by heterotrimeric G proteins minireview series.
Vaughan M.
J. Biol. Chem. 1998 Jan 9;273(2):667-8.
[Text Abstract on PubMed]

Characterization of an ADP-ribosylation factor-like 1 protein in Saccharomyces cerevisiae.
Lee FJ, Huang CF, Yu WL, Buu LM, Lin CY, Huang MC, Moss J, Vaughan M.
J. Biol. Chem. 1997 Dec 5;272(49):30998-1005.
[Text Abstract on PubMed]

Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor.
Morinaga N, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1997 Nov 25;94(24):12926-31.
[Text Abstract on PubMed]

Characterization of a GDP dissociation inhibitory region of ADP-ribosylation factor domain protein ARD1.
Vitale N, Moss J, Vaughan M.
J. Biol. Chem. 1997 Oct 3;272(40):25077-82.
[Text Abstract on PubMed]

Identification and characterization of an ADP-ribosylation factor in Plasmodium falciparum.
Lee FJ, Patton WA, Lin CY, Moss J, Vaughan M, Goldman ND, Syin C.
Mol. Biochem. Parasitol. 1997 Aug;87(2):217-23.
[Text Abstract on PubMed]

Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor.
Meacci E, Tsai SC, Adamik R, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1997 Mar 4;94(5):1745-8.
[Text Abstract on PubMed]

Interaction of the GTP-binding and GTPase-activating domains of ARD1 involves the effector region of the ADP-ribosylation factor domain.
Vitale N, Moss J, Vaughan M.
J. Biol. Chem. 1997 Feb 14;272(7):3897-904.
[Text Abstract on PubMed]

Activation of toxin ADP-ribosyltransferases by the family of ADP-ribosylation factors.
Vaughan M, Moss J.
Adv. Exp. Med. Biol. 1997;419:315-20.
[Text Abstract on PubMed]

Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain.
Morinaga N, Tsai SC, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1996 Nov 12;93(23):12856-60.
[Text Abstract on PubMed]

Characterization of a GTPase-activating protein that stimulates GTP hydrolysis by both ADP-ribosylation factor (ARF) and ARF-like proteins. Comparison to the ARD1 gap domain.
Ding M, Vitale N, Tsai SC, Adamik R, Moss J, Vaughan M.
J. Biol. Chem. 1996 Sep 27;271(39):24005-9.
[Text Abstract on PubMed]

Expression in human endothelial cells of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins involved in the initiation of vesicular transport.
Lee CM, Stevens LA, Hsu HC, Tsai SC, Lee YT, Moss J, Vaughan M.
J. Mol. Cell. Cardiol. 1996 Sep;28(9):1911-20.
[Text Abstract on PubMed]

Interspecies relationships among ADP-ribosylation factors (ARFs): evidence of evolutionary pressure to maintain individual identities.
Price SR, Nightingale MS, Tsuchiya M, Moss J, Vaughan M.
Mol. Cell. Biochem. 1996 Jun 7;159(1):15-23.
[Text Abstract on PubMed]

ARD1, a 64-kDa bifunctional protein containing an 18-kDa GTP-binding ADP-ribosylation factor domain and a 46-kDa GTPase-activating domain.
Vitale N, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1996 Mar 5;93(5):1941-4.
[Text Abstract on PubMed]

Purification and characterization of a guanine nucleotide-exchange protein for ADP-ribosylation factor from spleen cytosol.
Tsai SC, Adamik R, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1996 Jan 9;93(1):305-9.
[Text Abstract on PubMed]

Hydrophobicity and subunit interactions of rod outer segment proteins investigated using Triton X-114 phase partitioning.
Justice JM, Murtagh, Moss J, Vaughan M.
J. Biol. Chem. 1995 Jul 28;270(30):17970-6.
[Text Abstract on PubMed]

Structure and function of ARF proteins: activators of cholera toxin and critical components of intracellular vesicular transport processes.
Moss J, Vaughan M.
J. Biol. Chem. 1995 May 26;270(21):12327-30.
[Text Abstract on PubMed]

Isolation of an amino-terminal deleted recombinant ADP-ribosylation factor 1 in an activated nucleotide-free state.
Hong JX, Zhang X, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1995 Mar 28;92(7):3056-9.
[Text Abstract on PubMed]

Involvement of N-myristoylation in monoclonal antibody recognition sites on chimeric G protein alpha subunits.
Justice JM, Bliziotes MM, Stevens LA, Moss J, Vaughan M.
J. Biol. Chem. 1995 Mar 24;270(12):6436-9.
[Text Abstract on PubMed]

Different ARF domains are required for the activation of cholera toxin and phospholipase D.
Zhang GF, Patton WA, Lee FJ, Liyanage M, Han JS, Rhee SG, Moss J, Vaughan M.
J. Biol. Chem. 1995 Jan 6;270(1):21-4.
[Text Abstract on PubMed]

Activation of rat brain phospholipase D by ADP-ribosylation factors 1,5, and 6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes.
Massenburg D, Han JS, Liyanage M, Patton WA, Rhee SG, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1994 Nov 22;91(24):11718-22.
[Text Abstract on PubMed]

ADP-ribosylation factors: a family of approximately 20-kDa guanine nucleotide-binding proteins that activate cholera toxin.
Welsh CF, Moss J, Vaughan M.
Mol. Cell. Biochem. 1994 Sep;138(1-2):157-66.
[Text Abstract on PubMed]

Characterization of class II and class III ADP-ribosylation factor genes and proteins in Drosophila melanogaster.
Lee FJ, Stevens LA, Hall LM, Murtagh, Kao YL, Moss J, Vaughan M.
J. Biol. Chem. 1994 Aug 26;269(34):21555-60.
[Text Abstract on PubMed]

Characterization of a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae.
Lee FJ, Stevens LA, Kao YL, Moss J, Vaughan M.
J. Biol. Chem. 1994 Aug 19;269(33):20931-7.
[Text Abstract on PubMed]

Isolation of recombinant ADP-ribosylation factor 6, an approximately 20-kDa guanine nucleotide-binding protein, in an activated GTP-bound state.
Welsh CF, Moss J, Vaughan M.
J. Biol. Chem. 1994 Jun 3;269(22):15583-7.
[Text Abstract on PubMed]

Identification of a brefeldin A-insensitive guanine nucleotide-exchange protein for ADP-ribosylation factor in bovine brain.
Tsai SC, Adamik R, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1994 Apr 12;91(8):3063-6.
[Text Abstract on PubMed]

Effect of ADP-ribosylation factor amino-terminal deletions on its GTP-dependent stimulation of cholera toxin activity.
Hong JX, Haun RS, Tsai SC, Moss J, Vaughan M.
J. Biol. Chem. 1994 Apr 1;269(13):9743-5.
[Text Abstract on PubMed]

Alternative splicing of the guanine nucleotide-binding regulatory protein Go alpha generates four distinct mRNAs.
Murtagh, Moss J, Vaughan M.
Nucleic Acids Res. 1994 Mar 11;22(5):842-9.
[Text Abstract on PubMed]

Characterization of recombinant and endogenous ADP-ribosylation factors synthesized in Sf9 insect cells.
Kunz BC, Muczynski KA, Welsh CF, Stanley SJ, Tsai SC, Adamik R, Chang PP, Moss J, Vaughan M.
Biochemistry. 1993 Jul 6;32(26):6643-8.
[Text Abstract on PubMed]

ADP-ribosylation factors, 20,000 M(r) guanine nucleotide-binding protein activators of cholera toxin and components of intracellular vesicular transport systems.
Moss J, Vaughan M.
Cell. Signal. 1993 Jul;5(4):367-79.
[Text Abstract on PubMed]

Molecular characterization of a conserved, guanine nucleotide-dependent ADP-ribosylation factor in Drosophila melanogaster.
Murtagh, Lee FJ, Deak P, Hall LM, Monaco L, Lee CM, Stevens LA, Moss J, Vaughan M.
Biochemistry. 1993 Jun 15;32(23):6011-8.
[Text Abstract on PubMed]

Effects of brefeldin A and accessory proteins on association of ADP-ribosylation factors 1, 3, and 5 with Golgi.
Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.
J. Biol. Chem. 1993 May 25;268(15):10820-5.
[Text Abstract on PubMed]

ARD 1, a 64-kDa guanine nucleotide-binding protein with a carboxyl-terminal ADP-ribosylation factor domain.
Mishima K, Tsuchiya M, Nightingale MS, Moss J, Vaughan M.
J. Biol. Chem. 1993 Apr 25;268(12):8801-7.
[Text Abstract on PubMed]

Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi.
Haun RS, Tsai SC, Adamik R, Moss J, Vaughan M.
J. Biol. Chem. 1993 Apr 5;268(10):7064-8.
[Text Abstract on PubMed]

Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution.
Moss J, Stanley SJ, Vaughan M, Tsuji T.
J. Biol. Chem. 1993 Mar 25;268(9):6383-7.
[Text Abstract on PubMed]

Characterization of the gene for ADP-ribosylation factor (ARF) 2, a developmentally regulated, selectively expressed member of the ARF family of approximately 20-kDa guanine nucleotide-binding proteins.
Serventi IM, Cavanaugh E, Moss J, Vaughan M.
J. Biol. Chem. 1993 Mar 5;268(7):4863-72.
[Text Abstract on PubMed]

Effects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity.
Murayama T, Tsai SC, Adamik R, Moss J, Vaughan M.
Biochemistry. 1993 Jan 19;32(2):561-6.
[Text Abstract on PubMed]

ADP-ribosylation factors: protein activators of cholera toxin.
Moss J, Vaughan M.
Prog. Nucleic Acid Res. Mol. Biol. 1993;45:47-65.
[Text Abstract on PubMed]

Human and Giardia ADP-ribosylation factors (ARFs) complement ARF function in Saccharomyces cerevisiae.
Lee FJ, Moss J, Vaughan M.
J. Biol. Chem. 1992 Dec 5;267(34):24441-5.
[Text Abstract on PubMed]

Conservation of a 23-kDa human transplantation antigen in mammalian species.
Price SR, Nightingale MS, Bobak DA, Tsuchiya M, Moss J, Vaughan M.
Genomics. 1992 Dec;14(4):959-64.
[Text Abstract on PubMed]

Differential interaction of ADP-ribosylation factors 1, 3, and 5 with rat brain Golgi membranes.
Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1992 Oct 1;89(19):9272-6.
[Text Abstract on PubMed]

Pertussis toxin-catalyzed ADP-ribosylation of G(o) alpha with mutations at the carboxyl terminus.
Avigan J, Murtagh, Stevens LA, Angus CW, Moss J, Vaughan M.
Biochemistry. 1992 Aug 25;31(33):7736-40.
[Text Abstract on PubMed]

Guanine nucleotide-binding proteins in the intestinal parasite Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP-ribosylation factor.
Murtagh, Mowatt MR, Lee CM, Lee FJ, Mishima K, Nash TE, Moss J, Vaughan M.
J. Biol. Chem. 1992 May 15;267(14):9654-62.
[Text Abstract on PubMed]

Characterization of the human gene encoding ADP-ribosylation factor 1, a guanine nucleotide-binding activator of cholera toxin.
Lee CM, Haun RS, Tsai SC, Moss J, Vaughan M.
J. Biol. Chem. 1992 May 5;267(13):9028-34.
[Text Abstract on PubMed]

GTP but not GDP analogues promote association of ADP-ribosylation factors, 20-kDa protein activators of cholera toxin, with phospholipids and PC-12 cell membranes.
Walker MW, Bobak DA, Tsai SC, Moss J, Vaughan M.
J. Biol. Chem. 1992 Feb 15;267(5):3230-5.
[Text Abstract on PubMed]

ADP-ribosylation factor, a guanine nucleotide-binding protein activator of cholera toxin, is isolated in an activated state when expressed as a fusion protein in Escherichia coli.
Welsh CF, Moss J, Vaughan M.
Trans. Assoc. Am. Physicians. 1992;105:172-6.
[Text Abstract on PubMed]

Enhancement of cholera toxin-catalyzed ADP-ribosylation by guanine nucleotide-binding proteins.
Serventi IM, Moss J, Vaughan M.
Curr. Top. Microbiol. Immunol. 1992;175:43-67.
[Text Abstract on PubMed]

Activation of cholera toxin by ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins.
Moss J, Vaughan M.
Curr. Top. Cell. Regul. 1992;32:49-72.
[Text Abstract on PubMed]

Isolation and characterization of the human gene for ADP-ribosylation factor 3, a 20-kDa guanine nucleotide-binding protein activator of cholera toxin.
Tsai SC, Haun RS, Tsuchiya M, Moss J, Vaughan M.
J. Biol. Chem. 1991 Dec 5;266(34):23053-9.
[Text Abstract on PubMed]

Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteins.
Moss J, Vaughan M.
Mol. Microbiol. 1991 Nov;5(11):2621-7.
[Text Abstract on PubMed]

[Paraneoplastic neurologic syndromes].
Dubas F.
Presse Med. 1991 Jun 8;20(22):1041-6.
[Text Abstract on PubMed]

Differential expression during development of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding protein activators of cholera toxin.
Tsai SC, Adamik R, Tsuchiya M, Chang PP, Moss J, Vaughan M.
J. Biol. Chem. 1991 May 5;266(13):8213-9.
[Text Abstract on PubMed]

Guanine nucleotide dependent formation of a complex between choleragen (cholera toxin) a subunit and bovine brain ADP-ribosylation factor.
Tsai SC, Adamik R, Moss J, Vaughan M.
Biochemistry. 1991 Apr 16;30(15):3697-703.
[Text Abstract on PubMed]

Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells.
Tsuchiya M, Price SR, Tsai SC, Moss J, Vaughan M.
J. Biol. Chem. 1991 Feb 15;266(5):2772-7.
[Text Abstract on PubMed]

Different forms of Go alpha mRNA arise by alternative splicing of transcripts from a single gene on human chromosome 16.
Murtagh, Eddy R, Shows TB, Moss J, Vaughan M.
Mol. Cell. Biol. 1991 Feb;11(2):1146-55.
[Text Abstract on PubMed]

Soluble guanine nucleotide-dependent ADP-ribosylation factors in activation of adenylyl cyclase by cholera toxin.
Moss J, Tsai SC, Price SR, Bobak DA, Vaughan M.
Meth. Enzymol. 1991;195:243-56.
[Text Abstract on PubMed]

Guanine nucleotide-dependent ADP-ribosylation of soluble rho catalyzed by Clostridium botulinum C3 ADP-ribosyltransferase. Isolation and characterization of a newly recognized form of rhoA.
Williamson KC, Smith LA, Moss J, Vaughan M.
J. Biol. Chem. 1990 Dec 5;265(34):20807-12.
[Text Abstract on PubMed]

Mechanism of cholera toxin activation by a guanine nucleotide-dependent 19 kDa protein.
Noda M, Tsai SC, Adamik R, Moss J, Vaughan M.
Biochim. Biophys. Acta. 1990 May 16;1034(2):195-9.
[Text Abstract on PubMed]

Selective amplification of an mRNA and related pseudogene for a human ADP-ribosylation factor, a guanine nucleotide-dependent protein activator of cholera toxin.
Monaco L, Murtagh JJ, Newman KB, Tsai SC, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1990 Mar;87(6):2206-10.
[Text Abstract on PubMed]

Structural and functional characterization of ADP-ribosylation factors, 20 kDa guanine nucleotide-binding proteins that activate cholera toxin.
Moss J, Tsuchiya M, Tsai SC, Adamik R, Bobak DA, Price SR, Nightingale MS, Vaughan M.
Adv. Second Messenger Phosphoprotein Res. 1990;24:83-8.
[Text Abstract on PubMed]

Role of guanine nucleotide-binding proteins in Clostridium botulinum pathology: purification of substrates for Clostridium botulinum C3 ADP-ribosyltransferase with different requirements for GTP and phospholipids.
Williamson KC, Smith LA, Moss J, Vaughan M.
Trans. Assoc. Am. Physicians. 1990;103:281-8.
[Text Abstract on PubMed]

Tissue and species distribution of mRNA encoding two ADP-ribosylation factors, 20-kDa guanine nucleotide binding proteins.
Tsuchiya M, Price SR, Nightingale MS, Moss J, Vaughan M.
Biochemistry. 1989 Dec 12;28(25):9668-73.
[Text Abstract on PubMed]

Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein.
Noda M, Tsai SC, Adamik R, Bobak DA, Moss J, Vaughan M.
Biochemistry. 1989 Sep 19;28(19):7936-40.
[Text Abstract on PubMed]

Microinjection of a 19-kDa guanine nucleotide-binding protein inhibits maturation of Xenopus oocytes.
Bahnson TD, Tsai SC, Adamik R, Moss J, Vaughan M.
J. Biol. Chem. 1989 Sep 5;264(25):14824-8.
[Text Abstract on PubMed]

Expression of Go alpha mRNA and protein in bovine tissues.
Price SR, Tsai SC, Adamik R, Angus CW, Serventi IM, Tsuchiya M, Moss J, Vaughan M.
Biochemistry. 1989 May 2;28(9):3803-7.
[Text Abstract on PubMed]

Participation of a guanine nucleotide-binding protein cascade in cholera toxin activation of adenylate cyclase.
Vaughan M, Tsai SC, Noda M, Adamik R, Moss J.
J. Mol. Cell. Cardiol. 1989 Feb;21 Suppl 1:97-102.
[Text Abstract on PubMed]

Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA.
Price SR, Nightingale M, Tsai SC, Williamson KC, Adamik R, Chen HC, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1988 Aug;85(15):5488-91.
[Text Abstract on PubMed]

Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain.
Tsai SC, Noda M, Adamik R, Chang PP, Chen HC, Moss J, Vaughan M.
J. Biol. Chem. 1988 Feb 5;263(4):1768-72.
[Text Abstract on PubMed]

Purification and properties of calmodulin-activated cyclic nucleotide phosphodiesterase from mammalian brain.
Kincaid RL, Vaughan M.
Meth. Enzymol. 1988;159:557-73.
[Text Abstract on PubMed]

Preparation of fluorescent, cross-linking, and biotinylated calmodulin derivatives and their use in studies of calmodulin-activated phosphodiesterase and protein phosphatase.
Kincaid RL, Billingsley ML, Vaughan M.
Meth. Enzymol. 1988;159:605-26.
[Text Abstract on PubMed]

ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins.
Moss J, Vaughan M.
Adv. Enzymol. Relat. Areas Mol. Biol. 1988;61:303-79.
[Text Abstract on PubMed]

Signal transduction by guanine nucleotide-binding proteins: possible molecular basis for multiple forms of Go alpha mRNA.
Murtagh JJ, Price SR, Van Meurs KP, Angus CW, Moss J, Vaughan M.
Trans. Assoc. Am. Physicians. 1988;101:235-41.
[Text Abstract on PubMed]

Hydroxylamine-stable covalent linkage of myristic acid in G0 alpha, a guanine nucleotide-binding protein of bovine brain.
Schultz AM, Tsai SC, Kung HF, Oroszlan S, Moss J, Vaughan M.
Biochem. Biophys. Res. Commun. 1987 Aug 14;146(3):1234-9.
[Text Abstract on PubMed]

Enhancement of choleragen ADP-ribosyltransferase activities by guanyl nucleotides and a 19-kDa membrane protein.
Tsai SC, Noda M, Adamik R, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1987 Aug;84(15):5139-42.
[Text Abstract on PubMed]

Deduced amino acid sequence of bovine retinal Go alpha: similarities to other guanine nucleotide-binding proteins.
Van Meurs KP, Angus CW, Lavu S, Kung HF, Czarnecki SK, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1987 May;84(10):3107-11.
[Text Abstract on PubMed]

Effect of N6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes.
Elks ML, Jackson M, Manganiello VC, Vaughan M.
Am. J. Physiol. 1987 Mar;252(3 Pt 1):C342-8.
[Text Abstract on PubMed]

Cutting down trees: women, nutrition and agricultural change in the northern province of Zambia, 1920-1986.
Moore H, Vaughan M.
Afr Aff (Lond). 1987;86(345):523-40.
[Text Abstract on PubMed]

Modulation of calcineurin phosphotyrosyl protein phosphatase activity by calmodulin and protease treatment.
Kincaid RL, Martensen TM, Vaughan M.
Biochem. Biophys. Res. Commun. 1986 Oct 15;140(1):320-8.
[Text Abstract on PubMed]

Identification of the probable site of choleragen-catalyzed ADP-ribosylation in a Go alpha-like protein based on cDNA sequence.
Angus CW, Van Meurs KP, Tsai SC, Adamik R, Miedel MC, Pan YC, Kung HF, Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1986 Aug;83(16):5813-6.
[Text Abstract on PubMed]

Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
Halpern JL, Tsai SC, Adamik R, Kanaho Y, Bekesi E, Kung HF, Moss J, Vaughan M.
Mol. Pharmacol. 1986 May;29(5):515-9.
[Text Abstract on PubMed]

Direct comparison of Ca2+ requirements for calmodulin interaction with and activation of protein phosphatase.
Kincaid RL, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1986 Mar;83(5):1193-7.
[Text Abstract on PubMed]

Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Ha-ras-encoded p21.
Tsai SC, Adamik R, Moss J, Vaughan M, Manne V, Kung HF.
Proc. Natl. Acad. Sci. U.S.A. 1985 Dec;82(24):8310-4.
[Text Abstract on PubMed]

Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site.
West, Moss J, Vaughan M, Liu T, Liu TY.
J. Biol. Chem. 1985 Nov 25;260(27):14428-30.
[Text Abstract on PubMed]

Mechanism of inhibition of transducin GTPase activity by fluoride and aluminum.
Kanaho Y, Moss J, Vaughan M.
J. Biol. Chem. 1985 Sep 25;260(21):11493-7.
[Text Abstract on PubMed]

Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase.
Kincaid RL, Stith-Coleman IE, Vaughan M.
J. Biol. Chem. 1985 Jul 25;260(15):9009-15.
[Text Abstract on PubMed]

Activation and stabilization of the catalytic unit of adenylate cyclase.
Terman BI, Bitonti AJ, Moss J, Vaughan M.
Biochem. J. 1985 Apr 1;227(1):91-7.
[Text Abstract on PubMed]

Coupling of receptors to signal transducing components: use of anti-idiotypic antibodies to map the specific sites of interaction of receptors and guanyl nucleotide-binding proteins.
Chang PP, Halpern J, Sohn RL, Kanaho Y, Moss J, Vaughan M.
Trans. Assoc. Am. Physicians. 1985;98:131-5.
[Text Abstract on PubMed]

Altered regulation of adenylate cyclase after toxin-catalyzed ADP-ribosylation.
Vaughan M, Moss J.
Curr. Top. Cell. Regul. 1985;27:243-51.
[Text Abstract on PubMed]

Pertussis toxin-catalyzed ADP-ribosylation of adenylate cyclase. Effects of guanyl nucleotides and rhodopsin.
Moss J, Tsai SC, Bruni P, Adamik R, Kanaho Y, Hewlett EL, Vaughan M.
Dev. Biol. Stand. 1985;61:43-9.
[Text Abstract on PubMed]

NIH conference. Cyclic nucleotides: mediators of bacterial toxin action in disease.
Moss J, Burns DL, Hsia JA, Hewlett EL, Guerrant RL, Vaughan M.
Ann. Intern. Med. 1984 Nov;101(5):653-66.
[Text Abstract on PubMed]

Purification and properties of calmodulin-stimulated phosphodiesterase from mammalian brain.
Kincaid RL, Manganiello VC, Odya CE, Osborne, Stith-Coleman IE, Danello MA, Vaughan M.
J. Biol. Chem. 1984 Apr 25;259(8):5158-66.
[Text Abstract on PubMed]

Requirement for both choleragen and pertussis toxin to obtain maximal activation of adenylate cyclase in cultured cells.
Hsia JA, Moss J, Hewlett EL, Vaughan M.
Biochem. Biophys. Res. Commun. 1984 Mar 30;119(3):1068-74.
[Text Abstract on PubMed]

Inhibition of bovine rod outer segment GTPase by Bordetella pertussis toxin.
Watkins PA, Moss J, Burns DL, Hewlett EL, Vaughan M.
J. Biol. Chem. 1984 Feb 10;259(3):1378-81.
[Text Abstract on PubMed]

ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding.
Hsia JA, Moss J, Hewlett EL, Vaughan M.
J. Biol. Chem. 1984 Jan 25;259(2):1086-90.
[Text Abstract on PubMed]

Toxin ADP-ribosyltransferases that act on adenylate cyclase systems.
Moss J, Vaughan M.
Meth. Enzymol. 1984;106:411-8.
[Text Abstract on PubMed]

Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
Manganiello VC, Yamamoto T, Elks M, Lin MC, Vaughan M.
Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;16:291-301.
[Text Abstract on PubMed]

Calcium-dependent interaction of dansyl-calmodulin and phosphodiesterase: relationship to Ca2+ requirement for enzyme activation.
Kincaid RL, Danello MA, Osborne, Tkachuk VA, Vaughan M.
Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;16:77-87.
[Text Abstract on PubMed]

NAD: arginine mono-ADP-ribosyltransferases from animal cells.
Moss J, Vaughan M.
Meth. Enzymol. 1984;106:430-7.
[Text Abstract on PubMed]

Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase.
Yamamoto T, Yamamoto S, Osborne, Manganiello VC, Vaughan M, Hidaka H.
J. Biol. Chem. 1983 Dec 10;258(23):14173-7.
[Text Abstract on PubMed]

Regulation of activity of purified guanylate cyclase from liver that is unresponsive to nitric oxide.
Tsai SC, Adamik R, Manganiello VC, Vaughan M.
Biochem. J. 1983 Dec 1;215(3):447-55.
[Text Abstract on PubMed]

Selective regulation by pertussis toxin of insulin-induced activation of particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes.
Elks ML, Watkins PA, Manganiello VC, Moss J, Hewlett E, Vaughan M.
Biochem. Biophys. Res. Commun. 1983 Oct 31;116(2):593-8.
[Text Abstract on PubMed]

Purification and characterization of cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from calf liver. Effects of divalent cations on activity.
Yamamoto T, Manganiello VC, Vaughan M.
J. Biol. Chem. 1983 Oct 25;258(20):12526-33.
[Text Abstract on PubMed]

Ca2+-independent cyclic GMP phosphodiesterases from rat liver and HTC hepatoma cells.
Strewler GJ, Danello MA, Manganiello VC, Vaughan M.
Biochem. J. 1983 Aug 1;213(2):379-86.
[Text Abstract on PubMed]

Hormone-sensitive particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. Regulation of responsiveness by dexamethasone.
Elks ML, Manganiello VC, Vaughan M.
J. Biol. Chem. 1983 Jul 25;258(14):8582-7.
[Text Abstract on PubMed]

Bradykinin stimulates phospholipid methylation, calcium influx, prostaglandin formation, and cAMP accumulation in human fibroblasts.
Bareis DL, Manganiello VC, Hirata F, Vaughan M, Axelrod J.
Proc. Natl. Acad. Sci. U.S.A. 1983 May;80(9):2514-8.
[Text Abstract on PubMed]

Affinity chromatography of brain cyclic nucleotide phosphodiesterase using 3-(2-pyridyldithio)propionyl-substituted calmodulin linked to thiol-sepharose.
Kincaid RL, Vaughan M.
Biochemistry. 1983 Feb 15;22(4):826-30.
[Text Abstract on PubMed]

Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells.
Burns DL, Hewlett EL, Moss J, Vaughan M.
J. Biol. Chem. 1983 Feb 10;258(3):1435-8.
[Text Abstract on PubMed]

Release of guanyl nucleotides from the regulatory subunit of adenylate cyclase.
Burns DL, Moss J, Vaughan M.
J. Biol. Chem. 1983 Jan 25;258(2):1116-20.
[Text Abstract on PubMed]

Regulation by bradykinin of its receptor and of receptor-mediated prostacyclin formation in cultured human fibroblasts.
Roscher AA, Manganiello VC, Jelsema CL, Moss J, Vaughan M.
Trans. Assoc. Am. Physicians. 1983;96:175-81.
[Text Abstract on PubMed]

Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
Manganiello VC, Reed BC, Lieberman FS, Moss J, Lane MD, Vaughan M.
J Cyclic Nucleotide Protein Phosphor Res. 1983;9(2):143-54.
[Text Abstract on PubMed]

Subcellular localization and quantification of cholesterol in cultured human fibroblasts exposed to human low density lipoprotein.
Kruth HS, Blanchette-Mackie J, Avigan J, Gamble W, Vaughan M.
J. Lipid Res. 1982 Nov;23(8):1128-35.
[Text Abstract on PubMed]

Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I.
Kincaid RL, Vaughan M, Osborne, Tkachuk VA.
J. Biol. Chem. 1982 Sep 25;257(18):10638-43.
[Text Abstract on PubMed]

Characterization of the GTP-binding component of the adenylate cyclase system in isolated myocardial muscle cells.
Moss J, Burns DL, Chang PP, Cutilletta AF, Vaughan M.
J. Mol. Cell. Cardiol. 1982 Sep;14 Suppl 3:71-5.
[Text Abstract on PubMed]

Resolution and activity of adenylate cyclase components in a zwitterionic cholate derivative [3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate].
Bitonti AJ, Moss J, Hjelmeland L, Vaughan M.
Biochemistry. 1982 Jul 20;21(15):3650-3.
[Text Abstract on PubMed]

Cholera and cell regulation.
Vaughan M.
Hosp Pract (Hosp Ed). 1982 Jun;17(6):145-52.
[Text Abstract on PubMed]

Calmodulin-activated cyclic nucleotide phosphodiesterase from brain. Changes in molecular size assessed by gel filtration and electrophoresis.
Kincaid RL, Manganiello VC, Vaughan M.
J. Biol. Chem. 1981 Nov 10;256(21):11345-50.
[Text Abstract on PubMed]

Calmodulin-activated cyclic nucleotide phosphodiesterase from brain. Relationship of subunit structure to activity assessed by radiation inactivation.
Kincaid RL, Kempner E, Manganiello VC, Osborne, Vaughan M.
J. Biol. Chem. 1981 Nov 10;256(21):11351-5.
[Text Abstract on PubMed]

GTP stabilization of adenylate cyclase activated and ADP-ribosylated by choleragen.
Nakaya S, Watkins PA, Bitonti AJ, Hjelmeland LM, Moss J, Vaughan M.
Biochem. Biophys. Res. Commun. 1981 Sep 16;102(1):66-74.
[Text Abstract on PubMed]

Mechanism of action of choleragen and E. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation.
Moss J, Vaughan M.
Mol. Cell. Biochem. 1981 Jul 7;37(2):75-90.
[Text Abstract on PubMed]

Modification of calmodulin function by enzymatic carboxylic methylation.
Gagnon C, Kelly S, Manganiello V, Vaughan M, Odya C, Strittmatter W, Hoffman A, Hirata F.
Nature. 1981 Jun 11;291(5815):515-6.
[Text Abstract on PubMed]

Effects of d- and l-propranolol on the responsiveness of human fibroblasts to choleragen and prostaglandin E1.
Moss J, Manganiello VC, Hom BE, Nakaya S, Vaughan M.
Biochem. Pharmacol. 1981 Jun 1;30(11):1263-9.
[Text Abstract on PubMed]

Reversible inactivation of soluble liver guanylate cyclase by disulfides.
Tsai SC, Adamik R, Manganiello VC, Vaughan M.
Biochem. Biophys. Res. Commun. 1981 May 29;100(2):637-43.
[Text Abstract on PubMed]

ADP ribosylation of membrane proteins from human fibroblasts. Effect of prior exposure of cells to choleragen.
Watkins PA, Moss J, Vaughan M.
J. Biol. Chem. 1981 May 25;256(10):4895-9.
[Text Abstract on PubMed]

Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases.
Hirata F, del Carmine R, Nelson CA, Axelrod J, Schiffmann E, Warabi A, De Blas AL, Nirenberg M, Manganiello V, Vaughan M, Kumagai S, Green I, Decker JL, Steinberg AD.
Proc. Natl. Acad. Sci. U.S.A. 1981 May;78(5):3190-4.
[Text Abstract on PubMed]

Regulation of cyclic nucleotide phosphodiesterase activity.
Vaughan M, Danello MA, Manganiello VC, Strewler GJ.
Adv Cyclic Nucleotide Res. 1981;14:263-71.
[Text Abstract on PubMed]

Mono (ADP-ribosyl)transferases and their effects on cellular metabolism.
Vaughan M, Moss J.
Curr. Top. Cell. Regul. 1981;20:205-46.
[Text Abstract on PubMed]

Effects of nucleoside triphosphates on choleragen-activated brain adenylate cyclase.
Nakaya S, Moss J, Vaughan M.
Biochemistry. 1980 Oct 14;19(21):4871-4.
[Text Abstract on PubMed]

Products of reaction catalyzed by purified rat liver guanylate cyclase determined by 31p NMR spectroscopy.
Tsai SC, Shindo H, Manganiello VC, Adamik R, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1980 Oct;77(10):5734-7.
[Text Abstract on PubMed]

ADP-ribosyltransferase activity of mono- and multi-(ADP-ribosylated) choleragen.
Moss J, Stanley SJ, Watkins PA, Vaughan M.
J. Biol. Chem. 1980 Aug 25;255(16):7835-7.
[Text Abstract on PubMed]

Effects of GTP on choleragen-catalyzed ADP ribosylation of membrane and soluble proteins.
Watkins PA, Moss J, Vaughan M.
J. Biol. Chem. 1980 May 10;255(9):3959-63.
[Text Abstract on PubMed]

Prostaglandins increase GTP hydrolysis by membranes from human mononuclear cells.
Bitonti AJ, Moss J, Tandon NN, Vaughan M.
J. Biol. Chem. 1980 Mar 10;255(5):2026-9.
[Text Abstract on PubMed]

Quantification of low density lipoprotein binding and cholesterol accumulation by single human fibroblasts using fluorescence microscopy.
Kruth HS, Vaughan M.
J. Lipid Res. 1980 Jan;21(1):123-30.
[Text Abstract on PubMed]

Effect of cell density on binding and uptake of low density lipoprotein by human fibroblasts.
Kruth HS, Avigan J, Gamble W, Vaughan M.
J. Cell Biol. 1979 Dec;83(3):588-94.
[Text Abstract on PubMed]

Sequential adsorption-electrophoresis: combined procedure for purification of calcium-dependent cyclic nucleotide phosphodiesterase.
Kincaid RL, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1979 Oct;76(10):4903-7.
[Text Abstract on PubMed]

Arrest of cultured cells in the G1 phase of the cell cycle by indomethacin.
Bayer BM, Kruth HS, Vaughan M, Beaven MA.
J. Pharmacol. Exp. Ther. 1979 Jul;210(1):106-11.
[Text Abstract on PubMed]

Interaction of choleragen and thyrotropin with bovine thyroid adenylate cyclase.
Ross PS, Moss J, Vaughan M.
Endocrinology. 1979 Apr;104(4):1036-40.
[Text Abstract on PubMed]

Activation of adenylate cyclase by choleragen.
Moss J, Vaughan M.
Annu. Rev. Biochem. 1979;48:581-600.
[Text Abstract on PubMed]

Purification of guanylate cyclase from rat liver supernatant.
Tsai SC, Manganiello VC, Vaughan M.
J. Biol. Chem. 1978 Dec 10;253(23):8542-7.
[Text Abstract on PubMed]

Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells.
Gamble W, Vaughan M, Kruth HS, Avigan J.
J. Lipid Res. 1978 Nov;19(8):1068-70.
[Text Abstract on PubMed]

Isolation of an avian erythrocyte protein possessing ADP-ribosyltransferase activity and capable of activating adenylate cyclase.
Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1978 Aug;75(8):3621-4.
[Text Abstract on PubMed]

Activation of kidney guanylate cyclase by cobalt.
Tsai SC, Manganiello VC, Vaughan M.
Arch. Biochem. Biophys. 1978 Jul;189(1):155-60.
[Text Abstract on PubMed]

Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion.
Gallin JI, Sandler JA, Clyman RI, Manganiello VC, Vaughan M.
J. Immunol. 1978 Feb;120(2):492-6.
[Text Abstract on PubMed]

Mechanism of action of choleragen and the glycopeptide hormones: is the nicotinamide adenine dinucleotide glycohydrolase activity observed in purified hormone preparations intrinsic to the hormone?
Moss J, Ross PS, Agosto G, Birken S, Canfield RE, Vaughan M.
Endocrinology. 1978 Feb;102(2):415-9.
[Text Abstract on PubMed]

Phosphodiesterase activator from rat kidney cortex.
Strewler GJ, Manganiello VC, Vaughan M.
J. Biol. Chem. 1978 Jan 25;253(2):390-4.
[Text Abstract on PubMed]

Mechanism of action of choleragen.
Vaughan M, Moss J.
J. Supramol. Struct. 1978;8(4):473-88.
[Text Abstract on PubMed]

Choleragen activation of solubilized adenylate cyclase: requirement for GTP and protein activator for demonstration of enzymatic activity.
Moss J, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1977 Oct;74(10):4396-400.
[Text Abstract on PubMed]

Solubilization and characterization of hormone- responsive phosphodiesterase activity of rat fat cells.
Lovell-Smith CJ, Manganiello VC, Vaughan M.
Biochim. Biophys. Acta. 1977 Apr 27;497(2):447-58.
[Text Abstract on PubMed]

Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.
Moss J, Vaughan M.
J. Biol. Chem. 1977 Apr 10;252(7):2455-7.
[Text Abstract on PubMed]

Oxygen: influence on cyclic nucleotides and calcium sequestration in the human umbilical artery.
Clyman RI, Manganiello VC, Vaughan M.
Chest. 1977 Feb;71(2 suppl):247-9.
[Text Abstract on PubMed]

Effect of gangliosides and substrate analogues on the hydrolysis of nicotinamide adenine dinucleotide by choleragen.
Moss J, Osborne, Fishman PH, Brewer, Vaughan M, Brady RO.
Proc. Natl. Acad. Sci. U.S.A. 1977 Jan;74(1):74-8.
[Text Abstract on PubMed]

Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase.
Moss J, Manganiello VC, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1976 Dec;73(12):4424-7.
[Text Abstract on PubMed]

Effects of choleragen on hormonal responsiveness of adenylate cyclase in human fibroblasts and rat fat cells.
Manganiello VC, Lovell-Smith CJ, Vaughan M.
Biochim. Biophys. Acta. 1976 Nov 18;451(1):62-71.
[Text Abstract on PubMed]

Activation and inhibition of fat cell adenylate cyclase by fluoride.
Manganiello VC, Vaughan M.
J. Biol. Chem. 1976 Oct 25;251(20):6205-9.
[Text Abstract on PubMed]

Choleragen-mediated release of trapped glucose from liposomes containing ganglioside GM1.
Moss J, Fishman PH, Richards RL, Alving CR, Vaughan M, Brady RO.
Proc. Natl. Acad. Sci. U.S.A. 1976 Oct;73(10):3480-3.
[Text Abstract on PubMed]

Calcium uptake by subcellular fractions of human umbilical artery.
Clyman RI, Manganiello VC, Lovell-Smith CJ, Vaughan M.
Am. J. Physiol. 1976 Oct;231(4):1074-81.
[Text Abstract on PubMed]

Uptake and metabolism of gangliosides in transformed mouse fibroblasts. Relationship of ganglioside structure to choleragen response.
Fishman PH, Moss J, Vaughan M.
J. Biol. Chem. 1976 Aug 10;251(15):4490-4.
[Text Abstract on PubMed]

Effect of salicylates on histamine and L-histidine metabolism. Inhibition of imidazoleacetate phosphoribosyl transferase.
Moss J, De Mello MC, Vaughan M, Beaven MA.
J. Clin. Invest. 1976 Jul;58(1):137-41.
[Text Abstract on PubMed]

The relationships between obsessional personality, obsessions in depression, and symptoms of depression.
Vaughan M.
Br J Psychiatry. 1976 Jul;129:36-9.
[Text Abstract on PubMed]

Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness.
Moss J, Fishman PH, Manganiello VC, Vaughan M, Brady RO.
Proc. Natl. Acad. Sci. U.S.A. 1976 Apr;73(4):1034-7.
[Text Abstract on PubMed]

Effects of serotonin, carbamylcholine, and ascorbic acid on leukocyte cyclic GMP and chemotaxis.
Sandler JA, Gallin JI, Vaughan M.
J. Cell Biol. 1975 Nov;67(2PT.1):480-4.
[Text Abstract on PubMed]

Oxygen and cyclic nucleotides in human umbilical artery.
Clyman RI, Blacksin AS, Manganiello VC, Vaughan M.
Proc. Natl. Acad. Sci. U.S.A. 1975 Oct;72(10):3883-7.
[Text Abstract on PubMed]

The role of calcium in regulation of cyclic nucleotide content in human umbilical artery.
Clyman RI, Blacksin AS, Sandler JA, Manganiello VC, Vaughan M.
J. Biol. Chem. 1975 Jun 25;250(12):4718-21.
[Text Abstract on PubMed]